Related Experiment Video
Updated: Jun 21, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Challenges to heart failure medication prescribing post-hospitalization
Jiaqi Li1, Visopiano Sanyu2, Elise Coia1
1Department of Pharmacy, Cabrini Hospital, Malvern, Melbourne, VIC 3144, Australia.
Objectives:
To determine the prevalence of heart failure (HF) medication prescribing on discharge post-HF-related admission.
Methods:
A retrospective audit was conducted for 216 HF admissions over a period of 6 months; medication data from electronic records were collected for analysis.
Key Findings:
The prevalence of HF medication prescribing on discharge was: 32.9% (95% confidence interval: 26.6-39.6) renin-angiotensin-aldosterone system inhibitors, 10.6% (6.9-15.6) angiotensin receptor-neprilysin inhibitors, 31.5% (25.4-38.1) HF-specific beta-blockers, 42.6% (35.9-49.5) aldosterone receptor antagonists, and 11.6% (7.6-16.6) sodium-glucose cotransporter-2 inhibitors.
Conclusion:
HF medication prescribing remains relatively low despite the known benefits and recommendations listed in the guidelines.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

